The active ingredient in Ozempic is semaglutide, a GLP-1 receptor agonist, and it also contains inactive ingredients such as sodium chloride, disodium phosphate, and water for injection, which help stabilize the formulation for subcutaneous use
Come for the convenience
Studies have shown reduction in heart disease, diabetes, dementia, fatty liver, sleep apnea, asthma, addiction, and more
AstraZeneca is also spending big on US manufacturing, including a biologics site in Maryland, and capacity for cell therapy on both the west and east coasts
Additionally, GLP-1 RA initiation appeared to lower all-cause mortality compared with no intervention (HR = 0.5
The most reliable indicator of compromised medication is reduced efficacy